Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent

被引:29
|
作者
Loeper, J [1 ]
Louérat-Oriou, B [1 ]
Duport, C [1 ]
Pompon, D [1 ]
机构
[1] Univ Paris 06, CNRS, Lab Propre Associe, Ctr Genet Mol, F-91198 Gif Sur Yvette, France
关键词
D O I
10.1124/mol.54.1.8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CYP2D6, a xenobiotic metabolizing cytochrome P450 (P450), was found to be present in significant amount on the outer face of cell plasma membrane in addition to the regular microsomal location. Present work demonstrates that this external P450 is catalytically competent and that activity is supported by NADPH-P450 reductase present on the inner face of plasma membrane. Purified plasma membranes from yeast expressing CYP2D6 sustained NADPH- and cumene hydroperoxide-dependent dextromethorphan demethylation and NADPH-cytochrome c activity confirming previous observations in human hepatocytes. CYP2D6 found on the outside of plasma membrane (by differential immune-inhibition and acidic shift assays on transformed spheroplasts) was catalytically competent at the cell surface for NADPH-supported activities. Anti-yeast P450-reductase antibodies inhibited neither CYP2D6 nor P450-reductase activities upon incubation with intact spheroplasts. In contrast, both activities were inhibited on isolated plasma membrane fragments. This highly suggested a cytosolic-orientation of the plasma membrane P450-reductase. This finding was confirmed by immunostaining in confocal microscopy. Finally, gene deletion of P450-reductase caused a complete loss of plasma membrane NADPH-supported CYP2D6 activity, which suggests that the reductase participates to some degree in the transmembrane electron transfer chain. This work illustrates that the outside-exposed plasma membrane CYP2D6 is active and may play an important metabolic role.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 50 条
  • [31] The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine
    Mellar P. Davis
    Jade Homsi
    Supportive Care in Cancer, 2001, 9 : 442 - 451
  • [32] Effect of terbinafine on the pharmacokinetics and pharmacodynamics of desipramine in healthy volunteers identified as cytochrome P450 2D6 (CYP2D6) extensive metabolizers
    Madani, S
    Barilla, D
    Cramer, J
    Wang, YB
    Paul, C
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11): : 1211 - 1218
  • [33] ASSOCIATION OF CYTOCHROME P450 2D6 (CYP2D6) POLYMORPHISMS WITH SUSCEPTIBILITY TO HEAD & NECK SQUAMOUS CELL CARCINOMA & TREATMENT RESPONSE
    Yadav, S. S. B.
    Pant, M. C.
    Parmar, D.
    ANNALS OF ONCOLOGY, 2014, 25
  • [34] Cytochrome P450 2D6 (CYP2D6) is decreased in patients with PPH: A potential mechanism for anorexigen-induced pulmonary hypertension
    Geraci, MW
    Cutrell, JD
    Moore, MD
    Tuder, RM
    Voelkel, NF
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A163 - A163
  • [35] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
    Crews, K. R.
    Gaedigk, A.
    Dunnenberger, H. M.
    Klein, T. E.
    Shen, D. D.
    Callaghan, J. T.
    Kharasch, E. D.
    Skaar, T. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (02) : 321 - 326
  • [36] Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro
    Liang, Bingqing
    Zhan, Yunyun
    Huang, Xiangxin
    Gu, Ermin
    Dai, Dapeng
    Cai, Jianping
    Hu, Guoxin
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2016, 41 (06) : 759 - 765
  • [37] Mechanism-based inhibition of human liver microsomal cytochrome P450 2D6 (CYP2D6) by alkamides of Piper nigrum
    Subehan
    Usia, Tepy
    Kadota, Shigetoshi
    Tezuka, Yasuhiro
    PLANTA MEDICA, 2006, 72 (06) : 527 - 532
  • [38] Impact of cytochrome P450 2D6 (CYP2D6) genotypes on metoprolol response rate and adverse effects among hypertensives.
    Zineh, I
    Beitelshees, AL
    Walker, JR
    Puckett, BJ
    Pauly, DF
    Phillips, MS
    Gelfand, CA
    Johnson, JA
    PHARMACOTHERAPY, 2003, 23 (10): : 1357 - 1357
  • [39] Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro
    Bingqing Liang
    Yunyun Zhan
    Xiangxin Huang
    Ermin Gu
    Dapeng Dai
    Jianping Cai
    Guoxin Hu
    European Journal of Drug Metabolism and Pharmacokinetics, 2016, 41 : 759 - 765
  • [40] Description of new cytochrome P450 2D6 (CYP2D6) alleles resulting from aberrant crossover between CYP2136 and CYP2D7
    Kramer, Whitney E.
    Dukek, Brian A.
    Bruflat, Jamie K.
    Walker, Denise A.
    O'Kane, Dennis J.
    Mrazek, David A.
    Black, John Logan
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 126S - 126S